athenahealth, Inc (ATHN) Expected to Announce Quarterly Sales of $319.54 Million

Wall Street analysts expect athenahealth, Inc (NASDAQ:ATHN) to post $319.54 million in sales for the current quarter, Zacks reports. Eleven analysts have made estimates for athenahealth’s earnings. The lowest sales estimate is $312.62 million and the highest is $331.94 million. athenahealth reported sales of $285.40 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 12%. The company is expected to issue its next quarterly earnings report on Thursday, April 26th.

According to Zacks, analysts expect that athenahealth will report full-year sales of $319.54 million for the current financial year, with estimates ranging from $1.33 billion to $1.36 billion. For the next financial year, analysts anticipate that the business will report sales of $1.49 billion per share, with estimates ranging from $1.45 billion to $1.59 billion. Zacks’ sales averages are an average based on a survey of analysts that follow athenahealth.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million during the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The firm’s revenue was up 14.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.62 EPS.

A number of research analysts recently issued reports on ATHN shares. KeyCorp reiterated a “buy” rating and set a $152.00 price objective on shares of athenahealth in a research note on Friday, January 12th. ValuEngine downgraded athenahealth from a “hold” rating to a “sell” rating in a research note on Friday, February 2nd. BidaskClub downgraded athenahealth from a “hold” rating to a “sell” rating in a research note on Tuesday, January 16th. Cantor Fitzgerald reiterated a “hold” rating and set a $120.00 price objective on shares of athenahealth in a research note on Friday, October 27th. Finally, Deutsche Bank assumed coverage on athenahealth in a research note on Friday, December 8th. They set a “hold” rating and a $145.00 price objective for the company. Three research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and seven have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $144.23.

In other news, Director Amy Abernethy sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $134.18, for a total transaction of $67,090.00. Following the sale, the director now directly owns 4,045 shares of the company’s stock, valued at approximately $542,758.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Brandon H. Hull sold 653 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $133.00, for a total value of $86,849.00. Following the sale, the director now directly owns 5,230 shares in the company, valued at $695,590. The disclosure for this sale can be found here. Insiders have sold a total of 97,903 shares of company stock worth $13,383,150 over the last ninety days. Insiders own 3.20% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Rockefeller Financial Services Inc. raised its holdings in shares of athenahealth by 293.2% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock worth $1,133,000 after acquiring an additional 6,793 shares in the last quarter. Toronto Dominion Bank raised its holdings in athenahealth by 83.3% during the 3rd quarter. Toronto Dominion Bank now owns 220,000 shares of the health services provider’s stock valued at $27,356,000 after buying an additional 100,000 shares during the period. Perceptive Advisors LLC purchased a new stake in athenahealth during the 3rd quarter valued at $8,705,000. Fox Run Management L.L.C. purchased a new stake in athenahealth during the 3rd quarter valued at $460,000. Finally, Sei Investments Co. raised its holdings in athenahealth by 36.6% during the 3rd quarter. Sei Investments Co. now owns 128,190 shares of the health services provider’s stock valued at $15,942,000 after buying an additional 34,332 shares during the period.

Shares of athenahealth (NASDAQ ATHN) traded up $1.66 during trading hours on Wednesday, hitting $139.88. The company had a trading volume of 238,302 shares, compared to its average volume of 607,906. The company has a market cap of $5,660.00, a P/E ratio of 112.81, a PEG ratio of 2.66 and a beta of 1.35. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth has a 52 week low of $95.01 and a 52 week high of $158.66.

COPYRIGHT VIOLATION WARNING: This story was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/25/athenahealth-inc-athn-expected-to-announce-quarterly-sales-of-319-54-million.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply